The Weekly Summary

January 20th – January 26th                                 2020

In the general news, President Trump traveled to Davos, Switzerland, to avoid the impeachment Continue reading

Posted in - The Weekly Summary | Leave a comment

How human behavior has changed since 1950

January 26, 2020- by Seven E. Greer, MD

What defines the generations? What fundamentally changed the way we behave? Continue reading

Posted in - Opinion, - Policy, Bariatric surgery, Cardiac surgery, Cardiology, Diabetes and endocrinology, Genetics, Geriatrics, Internal Medicine, Oncology, Orthopedic surgery, Primary care medicine | Leave a comment

The best hospitals in the country are losing money. Why?

August 12, 2019- by Steven E. Greer, MD

In the course of working on a medical book for the patient population, I just discovered this 2017 Forbes article that explains Continue reading

Posted in - Policy, Cleveland Clinic, CMS, Columbia, Congress, Cornell, Harvard, NYU, Ohio State, UCLA, Univ Miami, Z Medical centers | Comments Off on The best hospitals in the country are losing money. Why?

The new CDC guidelines for prescribing opioid pain pills

June 1, 2016- Interviewed by Steven E. Greer, MD

Pain pill prescriptions have quadrupled since the 1990’s as drug companies stepped up marketing and funded Continue reading

Posted in - JAMA, - NEJM, - Pharma, CDC, Emergency medicine, General surgery, Oncology, Psychology Psychiatry, Rehab, Spine surgery, Sports medicine | Leave a comment

The Weekly Summary

January 13th – January 19th                                 2020

In the general news, The US-China trade deal, but only “Stage 1”, was signed with fanfare in The White Continue reading

Posted in - The Weekly Summary | Leave a comment

The ISCHEMIA trial PI, Judith Hochman, makes egregiously unfounded statements on national TV

November 17, 2019- by Steven E. Greer, MD

The big news from the 2019 American Heart Association meeting is the large trial known by the acronym ISCHEMIA. Continue reading

Posted in - Opinion, - Pharma, Cardiac surgery, Cardiology, Congress, FDA, Internal Medicine, NYU, VA | 1 Comment

The Healthcare Channel hits 10

February 3, 2017- by Steven E. Greer, MD I don’t recall the exact date, but it was sometime during the summer of 2006, when I was daydreaming Continue reading

Posted in - Opinion | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer,

Posted in - Biotech, - Generics, FDA | Leave a comment

Cardiology mafia egregiously obfuscates mortality differences between stents and CABG in EXCEL trial

December 10, 2019- by Steven E. Greer, MD

In my recent book, The Medical Advocate, I excoriated the cardiology community, particularly Continue reading

Posted in - Medical Devices, - NEJM, - Opinion, Cardiac surgery, Cardiology, FDA | Leave a comment

Daily aspirin once again proves to be of no use and also deadly

Japanese-aspirin-studyUpdate January 13, 2015- Yet another study was published highlighting the risks of daily aspirin.  Continue reading

Posted in - JAMA, - Pharma, - Policy, Cardiac surgery, Cardiology, Gastroenterology and liver, General surgery, Neurology, Neurosurgery, Oncology, Primary care medicine | Leave a comment

The Weekly Summary

January 6th – January 12th                                 2020

In the general news, Iran seemingly blinked and failed to retaliate meaningfully after the U.S. Continue reading

Posted in - The Weekly Summary | Leave a comment

Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital.

Dean and CEO of Johns Hopkins Medicine Paul Rothman

December 11, 2018- by Steven E. Greer, MD

Ranking colleges and medical centers is a futile, highly subjective, and ludicrous endeavor. Nevertheless, Continue reading

Posted in - Policy, Cardiac surgery, Cardiology, Columbia, Johns Hopkins, Pediatrics | 3 Comments

The MusiCorps benefit concert 2015

October 16, 2015- by Steven E. Greer, MD

We interviewed the Founder of MusiCorps, Arthur Bloom, and one of the musicians in the band, Continue reading

Posted in - Policy, NIH, Orthopedic surgery, Plastic surgery, Psychology Psychiatry, Trauma Surgery, VA Walter Reed | Leave a comment

Crystalloid “Balanced Lactated Ringer’s” IV solution is safer to the kidneys

March 1, 2018- Interviewed by Steven E. Greer, MD

We interviewed Vanderbilt’s Todd Rice, MD about his NEJM papers that showed crystalloid, or Continue reading

Posted in - NEJM, Cardiac surgery, Cardiology, Emergency medicine, General surgery, Internal Medicine, Neurology, Neurosurgery, Obstetrics and Gynecology, Oncology, Orthopedic surgery, Pediatrics, Plastic surgery, Sports medicine, Trauma Surgery, Urology, Vanderbilt, Vascular Surgery | Leave a comment

Don Berwick, MD: Waste in the American Healthcare System

Dr. Berwick, former Director of CMS and former President and CEO of IHI, discusses the percentage Continue reading

Posted in CMS, Congress, Harvard | Leave a comment

The Who’s Teen Cancer Lounge at Sloan Kettering opens

March 18, 2016- by Steven E. Greer MD

The Memorial Sloan Kettering Cancer Center held a press day for its new teen lounge Continue reading

Posted in Memorial Sloan-Kettering, Oncology | Leave a comment

Celiac disease is not reduced by breast feeding or delaying the introduction of gluten

October 19, 2014- Interviewed by Steven E. Greer, MD

Alessio Fasano, MD of Harvard discusses his 10-year-long study in children testing whether the Continue reading

Posted in - NEJM, Gastroenterology and liver, Harvard, Pediatrics, Primary care medicine | Leave a comment

Is Vitamin-D deficiency overdiagnosed?

November 8, 2016- Interviewed by Steven E. Greer, MD

We interviewed JoAnn E. Manson, MD, DrPH, Chief, Division of Preventive Medicine,  Brigham Continue reading

Posted in - NEJM, - Policy, CDC, Diabetes and endocrinology, FDA, Harvard, Primary care medicine | Leave a comment

Benjamin Sommers, MD PhD: Expansion of Medicaid and impact on mortality rates

September 7, 2012

Posted in CMS, Harvard | Leave a comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD

We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber, Continue reading

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment